212 related articles for article (PubMed ID: 11564242)
21. Potential of MR spectroscopy for assessment of glioma grading.
Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
[TBL] [Abstract][Full Text] [Related]
22. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas.
McKnight TR; Lamborn KR; Love TD; Berger MS; Chang S; Dillon WP; Bollen A; Nelson SJ
J Neurosurg; 2007 Apr; 106(4):660-6. PubMed ID: 17432719
[TBL] [Abstract][Full Text] [Related]
23. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.
Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM
Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540
[TBL] [Abstract][Full Text] [Related]
24. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
Stadlbauer A; Nimsky C; Buslei R; Pinker K; Gruber S; Hammen T; Buchfelder M; Ganslandt O
Invest Radiol; 2007 Apr; 42(4):218-23. PubMed ID: 17351427
[TBL] [Abstract][Full Text] [Related]
25. Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.
Widhalm G; Krssak M; Minchev G; Wöhrer A; Traub-Weidinger T; Czech T; Asenbaum S; Marosi C; Knosp E; Hainfellner JA; Prayer D; Wolfsberger S
J Neurol Neurosurg Psychiatry; 2011 May; 82(5):512-20. PubMed ID: 20971752
[TBL] [Abstract][Full Text] [Related]
26. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
Chan AA; Lau A; Pirzkall A; Chang SM; Verhey LJ; Larson D; McDermott MW; Dillon WP; Nelson SJ
J Neurosurg; 2004 Sep; 101(3):467-75. PubMed ID: 15352605
[TBL] [Abstract][Full Text] [Related]
27. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
28. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
Preul MC; Caramanos Z; Villemure JG; Shenouda G; LeBlanc R; Langleben A; Arnold DL
Neurosurgery; 2000 Feb; 46(2):306-18. PubMed ID: 10690719
[TBL] [Abstract][Full Text] [Related]
29. [Magnetic resonance imaging with spectroscopy, perfusion and cerebral diffusion in the diagnosis of brain tumours].
Fayed-Miguel N; Morales-Ramos H; Modrego-Pardo PJ
Rev Neurol; 2006 Jun 16-30; 42(12):735-42. PubMed ID: 16775800
[TBL] [Abstract][Full Text] [Related]
30. Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.
Sankar T; Caramanos Z; Assina R; Villemure JG; Leblanc R; Langleben A; Arnold DL; Preul MC
J Neurooncol; 2008 Oct; 90(1):63-76. PubMed ID: 18600428
[TBL] [Abstract][Full Text] [Related]
31. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
García-Martín ML; Hérigault G; Rémy C; Farion R; Ballesteros P; Coles JA; Cerdán S; Ziegler A
Cancer Res; 2001 Sep; 61(17):6524-31. PubMed ID: 11522650
[TBL] [Abstract][Full Text] [Related]
32. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
33. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
34. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
Ziegler A; von Kienlin M; Décorps M; Rémy C
Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
[TBL] [Abstract][Full Text] [Related]
35. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
36. [Magnetic resonance spectroscopy of brain tumors].
Ditter P; Hattingen E
Radiologe; 2017 Jun; 57(6):450-458. PubMed ID: 28331947
[TBL] [Abstract][Full Text] [Related]
37. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
38. An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
Liu H; Hall WA; Martin AJ; Truwit CL
J Magn Reson Imaging; 2001 Jul; 14(1):1-7. PubMed ID: 11436207
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
[TBL] [Abstract][Full Text] [Related]
40. Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment.
Lotumolo A; Caivano R; Rabasco P; Iannelli G; Villonio A; D' Antuono F; Gioioso M; Zandolino A; Macarini L; Guglielmi G; Cammarota A
Eur J Radiol; 2015 Dec; 84(12):2597-604. PubMed ID: 26391231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
